Pharmafile Logo

Peter Impey

- PMLiVE

NICE to support development of HTA in India

UK health standards body will share expertise with India’s Department of Health Research

Novartis building

US FDA deems Novartis’ heart failure candidate a ‘breakthrough’

Serelaxin demonstrates ability to reduce shortness of breath and lower chance of dying

EU flag

EC fines pharma companies €146m for generic Celexa delay

Lundbeck, Alpharma, Merck KGaA, Generics UK, Arrow and Ranbaxy all hit

- PMLiVE

Andrea Cracraft joins clinical research organisation PSI

Takes up role as director of clinical operations for North America

- PMLiVE

NCHA conference to showcase the latest home healthcare developments

October event will take aim at the new future for out-of-hospital care

- PMLiVE

Quanticate expands and relocates to Research Triangle

CRO moves to North Carolina after partnership-driven growth

GE Healthcare plans $2bn software investment

Will focus on the convergence of machine and intelligent data

- PMLiVE

BMS appoints Dinesh Paliwal to board

He is CEO of audio firm Harman International

- PMLiVE

Pay-for-delay deals ‘sometimes violate antitrust law’

US Supreme Court rules on deals between pharma and generic drug companies

- PMLiVE

J&J extends open innovation with Stevenage office

Site at Stevenage Bioscience Catalyst expands London Innovation Centre operations

- PMLiVE

Setback for AZ and BMS as Onglyza flunks cardiovascular trial

Diabetes drug fails to show benefit over placebo

- PMLiVE

BRIC ‘not delivering’ on promises of high growth

Frost & Sullivan report highlights the difficulties for pharma working in BRIC markets

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links